---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-028260"
form_type: "8-K"
ticker: "GTBP"
cik: "0000109657"
company_name: "GT Biopharma, Inc."
filed_at: "2022-10-12T23:59:59+00:00"
generated_at: "2026-06-23T04:00:08.643856+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# GT Biopharma shareholders vote to reduce authorized common stock from 750M to 250M shares

## Summary
- Special meeting held Oct 10, 2022; 17,442,945 of 31,092,498 shares represented (56.1%).
- Proposal to ratify amendment reducing authorized common stock from 750M to 250M shares passed.
- Vote: 17,201,108 For, 227,621 Against, 14,216 Abstain.
- The amendment was previously proposed at the 2022 Annual Meeting as Proposal No. 4.

## SEC filing metadata
- accession: 0001493152-22-028260
- form_type: 8-K
- ticker: GTBP
- cik: 0000109657
- company_name: GT Biopharma, Inc.
- filed_at: 2022-10-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/109657/000149315222028260/0001493152-22-028260-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/109657/000149315222028260/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-028260
- JSON: https://secwatch.observer/filing/0001493152-22-028260.json
- Plain text: https://secwatch.observer/filing/0001493152-22-028260.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.